Calidi Biotherapeutics (CLDWW) Q3 2024 Earnings

Aug 13Confirmed
Q3 2024
-1.45
-1.43
-1.42
-1.4

Details

Expected EPS
-1.45
Actual EPS
-1.4
Surprise EPS
0.05
Surprise Percent
+3.45%

Description

⁨Calidi Biotherapeutics⁩ (⁦CLDWW⁩) has reported earnings of ⁦-1.4⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts